DiscoverX BioMAP® Phenotypic Profiling Services
If you are looking to advance compounds to the clinic, BioMAP® phenotypic profiling services will predict the behaviour of your drug candidates in patients…
BioMAP® is the only primary cell based screening platform that models human disease in vitro. The BioMAP® service offers over 50 biologically relevant systems and promises to deliver actionable data for better drug development decision making.
BioMAP® provides insights into mechanism of action, compound efficacy and safety-related effects, and enables the correlation of compound activity with clinical outcomes.